Lupin 2024

IMS Institute for Healthcare Informatics

Balancing drug cost vs. access a challenge

Balancing drug cost vs. access a challenge

PARSIPPANY, N.J. — Growth in spending on medicines dipped last year, but that hasn’t eased the challenge of balancing access to drugs and the cost of care in an era of innovative but more expensive treatments, according to the IMS Institute for Healthcare Informatics. For the second year, medication spending climbed by double digits in

Global drug spending to climb steadily

Global drug spending to climb steadily

DANBURY, Conn. — More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31% a decade ago, as the “medicine use gap” between developed and pharmerging markets narrows, the IMS Institute for Healthcare Informatics projects. Global drug spending is

U.S. drug spending, scripts reach new highs

U.S. drug spending, scripts reach new highs

PARSIPPANY, N.J. — Specialty medications helped drive a double-digit gain in total spending on medicines in the United States for 2014, as well as record volume in prescriptions dispensed, according to the IMS Institute for Healthcare Informatics, a unit of IMS Health. Last year, U.S. spending on medicines rose 10.3% on a real per capita

PP_1170x120_10-25-21